MiR-145 is a well-known tumor suppressor [270], that inhibits the expression of ZEB1, a critical regulator of EMT, and embryonic transcription factors, Lin28, Nanog, OCT4, and SOX2 in a variety of cancer models [271,272]. The gene discussed is LIN28A; the disease is cancer.